ARTICLE | Company News
Advanced Accelerator Applications, Dompe deal
August 8, 2011 7:00 AM UTC
Advanced Accelerator received exclusive, worldwide rights to develop and commercialize Dompe's FabOvar. The iodine-131 labeled humanized mAb fragment is in preclinical testing to treat ovarian cancer,...